Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms
-
Aurora Mobile Limited Files Its Annual Report on Form 20-F
-
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
-
Kyivstar Delivered 4G Coverage to 630 Communities in 2025
-
Next Technology Holding Inc. Announces Closing of $157 Million Registered Direct Offering
-
ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label
-
Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position
-
ARMLOGI HOLDING CORP. EXPANDS INTERNAL MIDDLE-MILE TRANSPORTATION NETWORK ACROSS E-COMMERCE FULFILLMENT OPERATIONS
-
BTCS Reports 305% Year-Over-Year Revenue Growth to Record $16.5 Million for Full Year 2025
-
VisionWave Announces Completion of Internal Research Paper on Conceptual RF-Based Subsurface Sensing Architectures in Connection with Recent Liberia LOE Engagement
-
Three-Peat: Momentum Named Agency of the Year Again
-
IP Strategy Highlights GenoBank’s Expansion of Onchain Genomic Data on Story
-
OXB recognised as ‘Most Innovative CDMO (Cell & Gene)’ at 2026 CDMO Leadership Awards
-
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
-
Issue of Equity and Total Voting Rights
-
Portugal Golden Visa Shows Resilience Despite Citizenship Law Discussion, Get Golden Visa Report Finds
-
BingX Introduces 24/7 TradFi Trading, Unlocking Continuous Access to Global Markets
-
Arletta Pharma Solutions Announces Positive Results from Phase II Clitoral Doppler Duplex Ultrasound Study of Lybrido™ Combination Targeting Female Sexual Dysfunction
-
Lasse Ingemann Brodt handing over the Managing Director position of FK Distribution to Bjarne Werner Munck on 1 May 2026
-
Lexlegis Showcases Legal AID at NVIDIA GTC 2026; Announces U.S. Beta Launch, Signals Rise of the ‘Legal Intelligence Factory’
-
Norwegian Cruise Line Holdings Enters into Employment and Equity Award Agreements with President and CEO
-
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
-
RenX Enterprises Executes 1-for-20 Reverse Split, Creating One of Nasdaq’s Tightest Floats Amid Accelerating Revenue Growth
-
Streamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up Agreements
-
Precision Optics Corporation, Inc. Announces Pricing of Upsized $10 Million Public Offering of Common Stock
-
Super League Reports Fourth Quarter and Full Year 2025 Financial Results, Completes Business Transformation and Advances Path to Profitability
-
LM Funding America, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
-
Streamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up Agreements
-
Tallinna Vesi’s Supervisory Council approved the annual report for 2025 and the dividend proposal
-
Digitalist Group Plc has published Financial Statements of 2025, Report by the Board of Directors, Auditor’s Report, Corporate Governance Statement and Remuneration Report
-
Heimstaden 2026 Annual General Meeting
-
ALSTOM S.A: Alstom to deliver Belgrade’s first metro: A historic leap in urban mobility and economic growth
-
Sportradar Files Its Annual Report on Form 20-F
-
Premier American Uranium Announces 2026 New Mexico Work Program Targeting Optimization of Cebolleta Preliminary Economic Assessment
-
Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer
-
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
-
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
-
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Green Stream Holdings, Inc. Announces New Leadership and Board Appointments and Strategic Direction Involving Law90 and Subsidiaries
-
BOSS Zhipin Continued Share Repurchase, Total Repurchases Amount to Over RMB500 million in 2026
-
ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Growth for Full Year 2025
-
Aurora Mobile Partners with Soochow Securities to Advance Digital Transformation and Develop Intelligent Financial Services Platform
-
Hudbay Provides Annual Reserve and Resource Update with Mine Life Extensions and Improved Three-Year Production Outlook
-
BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting
-
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
-
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
-
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress
-
Legence Reports Fourth Quarter and Year End 2025 Financial Results
